Organogenesis Holdings Inc.
USD2.43
+0.01 (+0.41%)
CEO
Gary S. Gillheeney
IPO Date
2017-01-05
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$2.39
Prev. Close
$2.42
Day Low
$2.31
Day High
$2.44
52W Low
$2.04
52W High
$7.08
Market Cap
$0.31B
Volume
0.57M
| 489.4 |
| 31 Dec 2023 | FY | 75.4% | 1.1% | 1.8% | 1.1% | 0.43 | 2.80 | 108.5 |
| 31 Dec 2022 | FY | 76.7% | 3.4% | 5.8% | 3.5% | 0.47 | 2.97 | 22.5 |
| 31 Dec 2021 | FY | 75.6% | 20.2% | 39.0% | 21.3% | 0.55 | 2.74 | 12.6 |
| 31 Dec 2020 | FY | 74.2% | 5.1% | 12.2% | 5.9% | 0.60 | 2.56 | 47.1 |
| 31 Dec 2019 | FY | 70.9% | -14.8% | -69.6% | -17.5% | 1.81 | 2.10 | -11.5 |
| 31 Dec 2018 | FY | 64.4% | -33.5% | -137.8% | -39.6% | 1.26 | 1.07 | -10.8 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -0.7% | -0.7% | 0.06 | 0.07 | -302.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -0.1% | -0.1% | 0.00 | 3.00 | -400.8 |
| 3.8 |
| 30 Sept 2025 | Q3 | 75.9% | 14.3% | 5.6% | 4.2% | 0.11 | 3.32 | 6.2 |
| 30 Jun 2025 | Q2 | 72.6% | -9.3% | -2.6% | -2.0% | 0.11 | 3.95 | -12.4 |
| 31 Mar 2025 | Q1 | 72.6% | -21.7% | -5.1% | -4.0% | 0.12 | 4.12 | -7.2 |
| 31 Dec 2024 | Q4 | 75.5% | 6.1% | 2.0% | 1.5% | 0.11 | 3.69 | 13.7 |
| 30 Sept 2024 | Q3 | 76.7% | 10.7% | 4.4% | 2.8% | 0.39 | 3.09 | 7.7 |
| 30 Jun 2024 | Q2 | 77.6% | -13.1% | -6.5% | -3.8% | 0.43 | 2.73 | -5.3 |
| 31 Mar 2024 | Q1 | 73.9% | -1.9% | -0.8% | -0.5% | 0.43 | 2.74 | -44.0 |
| 31 Dec 2023 | Q4 | 72.1% | -0.6% | -0.2% | -0.1% | 0.43 | 2.80 | -235.7 |